Artrya Limited (ASX:AYA)

Australia flag Australia · Delayed Price · Currency is AUD
4.360
+0.350 (8.73%)
At close: Jan 16, 2026
425.30%
Market Cap689.25M
Revenue (ttm)28.00K
Net Income (ttm)-16.41M
Shares Out158.08M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume684,214
Average Volume691,154
Open4.010
Previous Close4.010
Day's Range3.940 - 4.380
52-Week Range0.560 - 5.240
Beta0.71
RSI53.26
Earnings DateFeb 19, 2026

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. [Read more]

Sector Healthcare
Founded 2018
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol AYA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.